Come up with a name for your new list and we'll add to it:
MabVax Therapeutics raised a round of funding on September 24, 2013. Investors include
National Cancer Institute.
MabVax Therapeutics is a clinical stage biotechnology company focused on the development of vaccine and antibody based therapies to address unmet medical needs in the treatment of cancer. MabVax is cr…